Ashburn, Michael
February 2012
Clinical Drug Investigation;2012 Supplement, Vol. 32 Issue S1, p1
Academic Journal
No abstract available.


Related Articles

  • Chronic Noncancer Pain Rehabilitation With Opioid Withdrawal: Comparison of Treatment Outcomes Based on Opioid Use Status at Admission. Rome, Jeffrey D.; Townsend, Cynthia O.; Bruce, Barbara K.; Sletten, Christopher D.; Luedtke, Connie A.; Hodgson, John E. // Mayo Clinic Proceedings;Jun2004, Vol. 79 Issue 6, p759 

    • Objective: To study differences in treatment outcomes between patients with chronic noncancer pain taking vs those not taking maintenance opioids at admission to a pain rehabilitation program. • Patients and Methods: A nonrandomized 2-group prepost design was used to compare 356...

  • Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Devulder, J.; Jacobs, A.; Richarz, U.; Wiggett, H. // BJA: The British Journal of Anaesthesia;Oct2009, Vol. 103 Issue 4, p576 

    Background: There is little evidence that short-acting opioids as rescue medication for breakthrough pain is an optimal long-term treatment strategy in chronic non-malignant pain. We compared clinical studies of long-acting opioids that allowed short-acting opioid rescue medication with those...

  • Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Vadivelu, Nalini; Kai, Alice; Maslin, Benjamin; Kodumudi, Gopal; Legler, Aron; Berger, Jack M. // Therapeutics & Clinical Risk Management;2015, Vol. 11, p95 

    Tapentadol, a μ-opioid agonist and norepinephrine reuptake inhibitor, has been found to be an effective medication for a wide variety of chronic pain conditions, including back pain, cancer-related pain, and arthritic pain. It has also been found to have fewer gastrointestinal side effects...

  • Principles of opioid use in chronic noncancer pain. Gardner-Nix, Jacqueline // CMAJ: Canadian Medical Association Journal;7/8/2003, Vol. 169 Issue 1, p38 

    Presents cases on the use of opioid in chronic noncancer pain. Information on the patients presented; Discussion on the diagnosis of pain; Insight on the physiological effect of opioids.

  • Ethical and practical issues with opioids in life-limiting illness. Fine, Robert L. // Baylor University Medical Center Proceedings;Jan2007, Vol. 20 Issue 1, p5 

    Effective pain relief, especially at the end of life, is a primary ethical obligation based upon the principles of beneficence, nonmaleficence, patient autonomy, and particularly the concept of double effect. The pragmatic foundation of pain management begins with a complete assessment, which...

  • Change Pain: Ever Evolving-An Update for 2016. Pergolizzi, Joseph; Paladini, Antonella; Varrassi, Giustino; Raffa, Robert // Pain & Therapy;Dec2016, Vol. 5 Issue 2, p127 

    Since 1986, the pharmacological management of pain was mainly based on the WHO 'analgesic ladder', with very few drugs available. The huge development of the basic knowledge on pain and its therapy, especially in the past 15 years, has made the 'guidelines' of WHO obsolete. That's why, during...

  • COMMENTARY. Eminson, Mary // Evidence Based Medicine;May2003, p89 

    The author discusses aspects of pain management wherein he thinks that psychological therapy is an effective treatment for chronic pain and distress in children and adolescents.

  • Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? Kissin, Igor // Journal of Pain Research;2013, Vol. 6, p513 

    Background: For the past 30 years, opioids have been used to treat chronic nonmalignant pain. This study tests the following hypotheses: (1) there is no strong evidence-based foundation for the conclusion that long-term opioid treatment of chronic nonmalignant pain is effective; and (2) the main...

  • Study reveals significant misuse of opioids among patients with pain.  // Reactions Weekly;9/5/2009, Issue 1268, p4 

    The article discusses a study on the misuse of opioid among patients with pain. Study authors administered 938,586 urine toxicology tests on more than 500,000 patients who were prescribed opioid analgesics for chronic pain management. They found that only 25 percent of patients had no evidence...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics